Long‐term outcome following multimodality treatment in a cat with recurrent laryngeal adenocarcinoma
2025

Long-term outcome of treatment in a cat with laryngeal cancer

Sample size: 1 publication Evidence: low

Author Information

Author(s): Christine Sesanto, Jessica Lawrence, Jocelyn Holkham, Juan Carlos Serra, Spela Bavcar, Magdalena Parys

Primary Institution: The Hospital for Small Animals, The University of Edinburgh

Hypothesis

Can multimodality treatment provide long-term control of recurrent laryngeal adenocarcinoma in cats?

Conclusion

The study demonstrates that multimodality treatment can achieve long-term control of recurrent laryngeal adenocarcinoma in a cat.

Supporting Evidence

  • The cat received two courses of radiation therapy over a period of 31.5 months.
  • Quality of life was reported as excellent during and after treatment.
  • No evidence of local recurrence was documented 42 months after the second course of treatment.

Takeaway

This study shows that a cat with throat cancer can live a long time after getting special treatments, including surgery and radiation.

Methodology

The cat received two courses of radiation therapy after surgeries for laryngeal adenocarcinoma, with monitoring for adverse effects and quality of life.

Limitations

The study is based on a single case, limiting generalizability.

Participant Demographics

A 9.5-year-old male neutered domestic short-haired cat.

Digital Object Identifier (DOI)

10.1111/vru.13466

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication